An academic–industrial collaboration delivering better starting points for drug discovery: new compound libraries driven by intelligent design

Abstract

An academic–industrial collaboration delivering better starting points for drug discovery: new compound libraries driven by intelligent design Project iDesign’s primary research objective is to deliver better starting points for early-stage drug discovery. To this end, we have synthesised compound libraries comprising molecules that are demonstrably novel, structurally and functionally diverse, and lead-like in character. Designed with safety considerations from the outset, our libraries interrogate underexplored regions of chemical space and therefore complement existing diversity sets.